Literature DB >> 2846362

Highly sensitive and reliable chemiluminescence method for the assay of superoxide dismutase in human erythrocytes.

H Kimura1, M Nakano.   

Abstract

Superoxide dismutase in human erythrocytes was assayed by the inhibition of highly diluted erythrocyte lysates on 2-methyl-6-(p-methoxyphenyl)-3,7-dihydroimidazol[1,2-alpha]pyra zin-3-one- dependent luminescence induced by the hypoxanthine-xanthine oxidase system. Our chemiluminescence procedure gave 95-times higher sensitivity than the cytochrome c method. The concentration of superoxide dismutase in erythrocytes of Down's syndrome patients was approx. 1.8-times higher than that of normal humans.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2846362     DOI： 10.1016/0014-5793(88)80949-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


  4 in total

1.  A new method for the quantification of superoxide dismutase mimics with an allopurinol-xanthine oxidase-lucigenin enhanced system.

Authors:  Bogdan Alexandru Stoica; Gabriela Bordeianu; Raluca Stanescu; Dragomir N Serban; Mihai Nechifor
Journal:  J Biol Inorg Chem       Date:  2011-04-23       Impact factor: 3.358

2.  Antiinflammatory reactivity of copper(I)-thionein.

Authors:  R Miesel; H J Hartmann; U Weser
Journal:  Inflammation       Date:  1990-10       Impact factor: 4.092

3.  Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain.

Authors:  Timothy Doyle; Zhoumou Chen; Carolina Muscoli; Leesa Bryant; Emanuela Esposito; Salvatore Cuzzocrea; Concetta Dagostino; Jan Ryerse; Smita Rausaria; Andrew Kamadulski; William L Neumann; Daniela Salvemini
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

4.  Rapid on-site dual optical system to measure specific reactive oxygen species (O2-• and OCl-) in a tiny droplet of whole blood.

Authors:  Kimiko Kazumura; Kozo Takeuchi; Akiko Hara; Toshiyuki Miwa; Masaki Hattori; Yuqiu Wu; Naokazu Morishita; Hiroshi Tsuchiya; Toshihiko Osawa
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.